The Respiratory Clinical Science Liaison will serve as a key clinical liaison to advanced practice health care providers (HCPs); deliver appropriate clinical and scientific information to support appropriate use of AstraZeneca respiratory products in a patient focused manner.
Provide support to clinicians who do not have access to genetic counselors or genetics expertise; help them implement a screening program for risk assessment, pre-test counseling and delivering results.
Delivers scientific and medical presentations that are not promotional in nature at national meetings in the USA, disseminates TEG knowledge at medical educational events, programs, meetings and conventions, medical congresses, hospital grand rounds.
Defined Target List, which the MSL will be held accountable for key interactions and strategic focus and plans. Support the sales efforts with interpretation of test results and fielding medical inquiries.
Support the portfolio of products through discussions and presentation of medical/scientific educational information to KOLs; develop and maintain a high level of expertise in relevant disease states and emerging treatment models.
The MSL will serve as a liaison to the medical/scientific community and will be responsible for establishing, developing and maintaining relationships with prominent experts in the dermatology/rheumatology Therapeutic Area within the geographic area of coverage.